272 related articles for article (PubMed ID: 16254372)
1. Establishment and maintenance of Kaposi's sarcoma-associated herpesvirus latency in B cells.
Chen L; Lagunoff M
J Virol; 2005 Nov; 79(22):14383-91. PubMed ID: 16254372
[TBL] [Abstract][Full Text] [Related]
2. Transcriptome analysis of Kaposi's sarcoma-associated herpesvirus during de novo primary infection of human B and endothelial cells.
Purushothaman P; Thakker S; Verma SC
J Virol; 2015 Mar; 89(6):3093-111. PubMed ID: 25552714
[TBL] [Abstract][Full Text] [Related]
3. Efficient infection of a human B cell line with cell-free Kaposi's sarcoma-associated herpesvirus.
Dollery SJ; Santiago-Crespo RJ; Kardava L; Moir S; Berger EA
J Virol; 2014 Feb; 88(3):1748-57. PubMed ID: 24257608
[TBL] [Abstract][Full Text] [Related]
4. Generation of high-titre virus stocks using BrK.219, a B-cell line infected stably with recombinant Kaposi's sarcoma-associated herpesvirus.
Kati S; Hage E; Mynarek M; Ganzenmueller T; Indenbirken D; Grundhoff A; Schulz TF
J Virol Methods; 2015 Jun; 217():79-86. PubMed ID: 25736227
[TBL] [Abstract][Full Text] [Related]
5. The KSHV viral interleukin-6 is not essential for latency or lytic replication in BJAB cells.
Chen L; Lagunoff M
Virology; 2007 Mar; 359(2):425-35. PubMed ID: 17074378
[TBL] [Abstract][Full Text] [Related]
6. Activation of the B cell antigen receptor triggers reactivation of latent Kaposi's sarcoma-associated herpesvirus in B cells.
Kati S; Tsao EH; Günther T; Weidner-Glunde M; Rothämel T; Grundhoff A; Kellam P; Schulz TF
J Virol; 2013 Jul; 87(14):8004-16. PubMed ID: 23678173
[TBL] [Abstract][Full Text] [Related]
7. Expression and Subcellular Localization of the Kaposi's Sarcoma-Associated Herpesvirus K15P Protein during Latency and Lytic Reactivation in Primary Effusion Lymphoma Cells.
Smith CG; Kharkwal H; Wilson DW
J Virol; 2017 Nov; 91(21):. PubMed ID: 28835496
[TBL] [Abstract][Full Text] [Related]
8. EphA7 Functions as Receptor on BJAB Cells for Cell-to-Cell Transmission of the Kaposi's Sarcoma-Associated Herpesvirus and for Cell-Free Infection by the Related Rhesus Monkey Rhadinovirus.
Großkopf AK; Schlagowski S; Hörnich BF; Fricke T; Desrosiers RC; Hahn AS
J Virol; 2019 Aug; 93(15):. PubMed ID: 31118261
[TBL] [Abstract][Full Text] [Related]
9. Evidence of inability of human cytomegalovirus to reactivate Kaposi's sarcoma-associated herpesvirus from latency in body cavity-based lymphocytes.
Cheng B; Martínez FP; Katano H; Tang Q
J Clin Virol; 2009 Nov; 46(3):244-8. PubMed ID: 19726225
[TBL] [Abstract][Full Text] [Related]
10. Use of the red fluorescent protein as a marker of Kaposi's sarcoma-associated herpesvirus lytic gene expression.
Vieira J; O'Hearn PM
Virology; 2004 Aug; 325(2):225-40. PubMed ID: 15246263
[TBL] [Abstract][Full Text] [Related]
11. Kaposi's Sarcoma-Associated Herpesvirus Increases PD-L1 and Proinflammatory Cytokine Expression in Human Monocytes.
Host KM; Jacobs SR; West JA; Zhang Z; Costantini LM; Stopford CM; Dittmer DP; Damania B
mBio; 2017 Oct; 8(5):. PubMed ID: 29018115
[TBL] [Abstract][Full Text] [Related]
12. Targeting Kaposi's Sarcoma-Associated Herpesvirus ORF21 Tyrosine Kinase and Viral Lytic Reactivation by Tyrosine Kinase Inhibitors Approved for Clinical Use.
Beauclair G; Naimo E; Dubich T; Rückert J; Koch S; Dhingra A; Wirth D; Schulz TF
J Virol; 2020 Feb; 94(5):. PubMed ID: 31826996
[TBL] [Abstract][Full Text] [Related]
13. Kaposi's Sarcoma-Associated Herpesvirus Latency Locus Renders B Cells Hyperresponsive to Secondary Infections.
Sin SH; Eason AB; Bigi R; Kim Y; Kang S; Tan K; Seltzer TA; Venkataramanan R; An H; Dittmer DP
J Virol; 2018 Oct; 92(19):. PubMed ID: 30021906
[TBL] [Abstract][Full Text] [Related]
14. KSHV Genome Replication and Maintenance in Latency.
Ueda K
Adv Exp Med Biol; 2018; 1045():299-320. PubMed ID: 29896673
[TBL] [Abstract][Full Text] [Related]
15. Differential viral protein expression in Kaposi's sarcoma-associated herpesvirus-infected diseases: Kaposi's sarcoma, primary effusion lymphoma, and multicentric Castleman's disease.
Parravicini C; Chandran B; Corbellino M; Berti E; Paulli M; Moore PS; Chang Y
Am J Pathol; 2000 Mar; 156(3):743-9. PubMed ID: 10702388
[TBL] [Abstract][Full Text] [Related]
16. Cyclooxygenase 2 induced by Kaposi's sarcoma-associated herpesvirus early during in vitro infection of target cells plays a role in the maintenance of latent viral gene expression.
Sharma-Walia N; Raghu H; Sadagopan S; Sivakumar R; Veettil MV; Naranatt PP; Smith MM; Chandran B
J Virol; 2006 Jul; 80(13):6534-52. PubMed ID: 16775340
[TBL] [Abstract][Full Text] [Related]
17. Epigenetic regulation of Kaposi's sarcoma-associated herpesvirus replication.
Pantry SN; Medveczky PG
Semin Cancer Biol; 2009 Jun; 19(3):153-7. PubMed ID: 19429478
[TBL] [Abstract][Full Text] [Related]
18. Persistent activation of STAT3 by latent Kaposi's sarcoma-associated herpesvirus infection of endothelial cells.
Punjabi AS; Carroll PA; Chen L; Lagunoff M
J Virol; 2007 Mar; 81(5):2449-58. PubMed ID: 17151100
[TBL] [Abstract][Full Text] [Related]
19. iTIME.219: An Immortalized KSHV Infected Endothelial Cell Line Inducible by a KSHV-Specific Stimulus to Transition From Latency to Lytic Replication and Infectious Virus Release.
Dollery SJ; Maldonado TD; Brenner EA; Berger EA
Front Cell Infect Microbiol; 2021; 11():654396. PubMed ID: 33937098
[TBL] [Abstract][Full Text] [Related]
20. Kaposi's sarcoma-associated herpesvirus LANA2 is a B-cell-specific latent viral protein that inhibits p53.
Rivas C; Thlick AE; Parravicini C; Moore PS; Chang Y
J Virol; 2001 Jan; 75(1):429-38. PubMed ID: 11119611
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]